CLINICAL_TRIALS
research
· 2016-05-16
Clinical Trial Update: Fault Detection, Zone MPC and DiAs System in T1D [NA]
Summary
Clinical trial update on fault detection, Zone MPC, and the DiAs system for managing Type 1 Diabetes. Sponsored by Rensselaer Polytechnic Institute.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rensselaer Polytechnic Institute | Conditions: Type 1 Diabetes | NA | Status: UNKNOWN